New Era Dawning in Lupus Treatment?
Hear Dr. David Wofsy of UCSF on “Biologic Therapy for Systemic Lupus Therapy” in NYC April 12th
The 2011 Paul Klemperer Award and Lecture:
Biologic Therapy for Systemic Lupus Erythematosus
A new era in the treatment of systemic lupus erythematosus (SLE) appears to be dawning.
More than a decade after the first approval of biologic therapy for rheumatoid arthritis, several exciting lines of investigation suggest that effective new biologic therapy for people with SLE may be close at hand.
Hear David Wofsy, M.D., professor of medicine and Microbiology/Immunology, at the University of California, San Francisco speak on this topic.
Date: April 20, 2011
Time: 6:30 PM - 8:00 PM
Location: The New York Academy of Medicine, 1216 Fifth Avenue at 103rd Street, New York, NY 10029
Reception: 6:30 PM to 7:00 PM
Lecture and Discussion: 7:00 PM to 8:00 PM
About David Wofsy, MD
Dr. Wofsy is Professor of Medicine and Microbiology/Immunology at the University of California, San Francisco.
He is best known for his research in murine (mouse) models for systemic lupus erythematosus (SLE), where he developed and tested several novel strategies for the treatment of SLE.
His current research is devoted to the conduct of clinical trials of biologic therapies for people with SLE.